Company: SISI
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001641172-25-010889
Chunk: 19

Company: SHINECO, INC.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 1
Chunk 19
---
 completion of all other follow-ups works, on August 16,
2021, the Company, through its subsidiary Tenet-Jove, completed the previously announced acquisition pursuant to the Restructuring Agreement
dated June 8, 2021.

On December 7, 2021, the Company established Shineco
Life Science Research Co., Ltd. (“Life Science”) as a wholly foreign-owned entity with registered capital of US$10.0 million.

On April 13, 2022, the Company established Shineco
Life Science Group Hong Kong Co., Limited (“Shineco Life”) as a wholly owned entity with registered capital of US$10.0 million.
On April 24, 2022, the Company entered into a Share Transfer Agreement with Shineco Life. Pursuant to the agreement, the Company transferred
its 100% of the equity interest of Life Science to Shineco Life. There was no consideration paid for the transfer, and after the transfer,
Life Science became a wholly-owned subsidiary of Shineco Life.

On May 16, 2023, Fuzhou Meida Health Management Co.,
Ltd (“Fuzhou Meida”), formerly known as Pangke Planet (Fuzhou) Health Management Co., Ltd, was established with registered
capital of RMB1.0 million (approximately US$0.1 million). Life Science owned an equity interest of 51% of Fuzhou Meida, and the remaining
49% equity interests was owned by two shareholders.

On May 16, 2023, Shinkang Technology (Jiangsu) Co.,
Ltd (“Shinkang”) was established with registered capital of RMB10.0 million (approximately US$1.4 million). Life Science owned
an equity interest of 51% of Shinkang, and the remaining 49% equity interests was owned by one shareholder. Shinkang is currently not
engaging in any active business operations.

On May 23, 2023, Life Science established Beijing
Shineco Chongshi Information Consulting Co., Ltd (“Chongshi”) as a wholly owned entity with registered capital of RMB0.1 million
(approximately US$0.01 million). On November 20, 2024, the Company entered into an agreement to transferred 100% equity interests in Chongshi
to a third party. See Note 8.

    7

On December 30, 2022, Shineco Life closed the acquisition